HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Denépoux, S. Articles by Lebecque, S. Search for Related Content PubMed PubMed Citation Articles by Denépoux, S. Articles by Lebecque, S. Pubmed/NCBI databases Substance via MeSH

T Cells Can Induce Somatic Mutation in B Cell Receptor-Engaged BL2 Burkitt’s Lymphoma Cells Independently of CD40-CD40 Ligand Interactions¹

Laboratory for Immunological Research, Schering-Plough, Dardilly, France

The B cell surface trigger(s) and the molecular mechanism(s) of somatic hypermutation remain unknown, partly because of the lack of amendable in vitro models. Recently, however, we reported that upon B cell receptor cross-linking and coculture with activated T cells, the Burkitt’s lymphoma cell line BL2 introduces mutations in its IgV_H gene in vitro. We now confirm the relevance of our culture model by establishing that the entire spectrum of somatic mutations observed in vivo, including insertions and deletions, could be found in the DNA of BL2 cells. Additionally, we show that among four human B cell lines, only two with a centroblast-like phenotype can be induced to mutate. Triggering of somatic mutations in BL2 cells requires intimate T-B cell contacts and is independent of CD40-CD40-ligand (CD40L) interactions as shown by 1) the lack of effect of anti-CD40 and/or anti-CD40L blocking Abs on somatic mutation and 2) the ability of a CD40L-deficient T cell clone (isolated from an X-linked hyper-IgM syndrome patient) to induce somatic mutation in B cell receptor-engaged BL2 cells. Thus, our in vitro model reveals that T-B cell membrane interactions through surface molecules different from CD40-CD40L can trigger somatic hypermutation.

This article has been cited by other articles:

				Y. Kluger, D. P. Tuck, J. T. Chang, Y. Nakayama, R. Poddar, N. Kohya, Z. Lian, A. B. Nasr, H. R. Halaban, D. S. Krause, et al. Lineage specificity of gene expression patterns PNAS, April 27, 2004; 101(17): 6508 - 6513. [Abstract] [Full Text] [PDF]

				H. Nagumo, K. Agematsu, N. Kobayashi, K. Shinozaki, S. Hokibara, H. Nagase, M. Takamoto, K. Yasui, K. Sugane, and A. Komiyama The different process of class switching and somatic hypermutation; a novel analysis by CD27- naive B cells Blood, January 15, 2002; 99(2): 567 - 575. [Abstract] [Full Text] [PDF]

				R. S. Harris, D. S. G. Croom-Carter, A. B. Rickinson, and M. S. Neuberger Epstein-Barr Virus and the Somatic Hypermutation of Immunoglobulin Genes in Burkitt's Lymphoma Cells J. Virol., November 1, 2001; 75(21): 10488 - 10492. [Abstract] [Full Text] [PDF]

				S. Bergthorsdottir, A. Gallagher, S. Jainandunsing, D. Cockayne, J. Sutton, T. Leanderson, and D. Gray Signals That Initiate Somatic Hypermutation of B Cells In Vitro J. Immunol., February 15, 2001; 166(4): 2228 - 2234. [Abstract] [Full Text] [PDF]

				A. M. Glas, E. H. N. van Montfort, J. Storek, E.-G. N. Green, R. P. M. Drissen, V. J. Bechtold, J. Z. Reilly, M. A. Dawson, and E. C. B. Milner B-cell-autonomous somatic mutation deficit following bone marrow transplant Blood, August 1, 2000; 96(3): 1064 - 1069. [Abstract] [Full Text] [PDF]

				V. Poltoratsky, C. J. Woo, B. Tippin, A. Martin, M. F. Goodman, and M. D. Scharff Expression of error-prone polymerases in BL2 cells activated for Ig somatic hypermutation PNAS, July 3, 2001; 98(14): 7976 - 7981. [Abstract] [Full Text] [PDF]